Green Cross (005250) - Total Liabilities
Based on the latest financial reports, Green Cross (005250) has total liabilities worth ₩2.40 Trillion KRW (≈ $1.63 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Green Cross (005250) cash conversion ratio to assess how effectively this company generates cash.
Green Cross - Total Liabilities Trend (2000–2024)
This chart illustrates how Green Cross's total liabilities have evolved over time, based on quarterly financial data. Check 005250 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Green Cross Competitors by Total Liabilities
The table below lists competitors of Green Cross ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Meihua International Medical Technologies Co Ltd
NASDAQ:MHUA
|
USA | $25.64 Million |
|
J.Kumar Infraprojects Limited
NSE:JKIL
|
India | Rs30.75 Billion |
|
Xinjiang Talimu Agriculture Development Co Ltd
SHG:600359
|
China | CN¥839.80 Million |
|
Globe Trade Centre S.A.
WAR:GTC
|
Poland | zł2.01 Billion |
|
American Battery Technology Company Common Stock
NASDAQ:ABAT
|
USA | $4.36 Million |
|
Camil Alimentos S.A
SA:CAML3
|
Brazil | R$7.91 Billion |
|
Orient Electric Limited
NSE:ORIENTELEC
|
India | Rs7.46 Billion |
|
First Copper Technology Co Ltd
TW:2009
|
Taiwan | NT$1.77 Billion |
Liability Composition Analysis (2000–2024)
This chart breaks down Green Cross's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Green Cross.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.98 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.56 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Green Cross's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Green Cross (2000–2024)
The table below shows the annual total liabilities of Green Cross from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩1.82 Trillion ≈ $1.23 Billion |
-2.03% |
| 2023-12-31 | ₩1.86 Trillion ≈ $1.26 Billion |
+14.22% |
| 2022-12-31 | ₩1.63 Trillion ≈ $1.10 Billion |
+2.45% |
| 2021-12-31 | ₩1.59 Trillion ≈ $1.07 Billion |
+1.17% |
| 2020-12-31 | ₩1.57 Trillion ≈ $1.06 Billion |
+23.71% |
| 2019-12-31 | ₩1.27 Trillion ≈ $858.81 Million |
+7.81% |
| 2018-12-31 | ₩1.18 Trillion ≈ $796.61 Million |
+4.86% |
| 2017-12-31 | ₩1.12 Trillion ≈ $759.70 Million |
+28.52% |
| 2016-12-31 | ₩872.27 Billion ≈ $591.12 Million |
+16.10% |
| 2015-12-31 | ₩751.28 Billion ≈ $509.13 Million |
+23.20% |
| 2014-12-31 | ₩609.81 Billion ≈ $413.26 Million |
+16.27% |
| 2013-12-31 | ₩524.46 Billion ≈ $355.42 Million |
+10.76% |
| 2012-12-31 | ₩473.51 Billion ≈ $320.89 Million |
-87.23% |
| 2011-12-31 | ₩3.71 Trillion ≈ $2.51 Billion |
+13.33% |
| 2010-12-31 | ₩3.27 Trillion ≈ $2.22 Billion |
+15.89% |
| 2009-12-31 | ₩2.82 Trillion ≈ $1.91 Billion |
+16.03% |
| 2008-12-31 | ₩2.43 Trillion ≈ $1.65 Billion |
+16.94% |
| 2007-12-31 | ₩2.08 Trillion ≈ $1.41 Billion |
+16.23% |
| 2006-12-31 | ₩1.79 Trillion ≈ $1.21 Billion |
+17.08% |
| 2005-12-31 | ₩1.53 Trillion ≈ $1.04 Billion |
+8.28% |
| 2004-12-31 | ₩1.41 Trillion ≈ $956.82 Million |
+1.32% |
| 2003-12-31 | ₩1.39 Trillion ≈ $944.32 Million |
+643.13% |
| 2002-12-31 | ₩187.51 Billion ≈ $127.07 Million |
-13.78% |
| 2001-12-31 | ₩217.49 Billion ≈ $147.39 Million |
+44.18% |
| 2000-12-31 | ₩150.84 Billion ≈ $102.22 Million |
-- |
About Green Cross
Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pert… Read more